Asmita Das

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Intellectual Disability

Natural Killer Cells

Vascular Endothelial Growth Factor

Top Venues

Cancer reports (Hoboken, N.J.)

Immunologic research

This page only lists publications with an associated author ORCID identifier.

Publications

Shweta Gulia, Prakash Chandra, Asmita Das
Natural Compound Dioscin Targeting Multiple Cancer Pathways through its High Affinity Binding to B Cell Lymphoma-2. Current computer-aided drug design (2024)
Amit Mathur, null Ritu, Prakash Chandra, Asmita Das
Autophagy: a necessary evil in cancer and inflammation. 3 Biotech 14 (3) (2024)
Amit Mathur, null Ritu, Prakash Chandra, Asmita Das
Autophagy: a necessary evil in cancer and inflammation. 3 Biotech 14 (3) (2024)
Amit Mathur, null Ritu, Prakash Chandra, Asmita Das
Autophagy: a necessary evil in cancer and inflammation. 3 Biotech 14 (3) (2024)
Amit Mathur, null Ritu, Prakash Chandra, Asmita Das
Autophagy: a necessary evil in cancer and inflammation. 3 Biotech 14 (3) (2024)
null Bharmjeet, Asmita Das
Racial disparities in cancer care, an eyeopener for developing better global cancer management strategies. Cancer reports (Hoboken, N.J.) (2023)
Sukrit Kashyap, Asmita Das
Exploring the complex and multifaceted interplay of the gut microbiome and cancer prevention and therapy. Acta microbiologica et immunologica Hungarica (2023)
Saksham Garg, Nikita Sharma, null Bharmjeet, Asmita Das
Unraveling the intricate relationship: Influence of microbiome on the host immune system in carcinogenesis. Cancer reports (Hoboken, N.J.) (2023)
Muskaan Dhingra, Shayon Mahalanobis, Asmita Das
Thyroid receptor β might be responsible for breast cancer associated with Hashimoto's thyroiditis: a new insight into pathogenesis. Immunologic research 70 (4) (2022)
Madhuri Chaurasia, Swapnil Gupta, Asmita Das, Bilikere S Dwarakanath, Anne Simonsen, Kulbhushan Sharma
Radiation induces EIF2AK3/PERK and ERN1/IRE1 mediated pro-survival autophagy. Autophagy 15 (8) (2019)
Richa Sharma, Asmita Das
IL-2 mediates NK cell proliferation but not hyperactivity. Immunologic research 66 (1) (2019)